We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Champions Oncology (CSBR) Soars: Stock Adds 10.7% in Session
Read MoreHide Full Article
Champions Oncology, Inc. (CSBR - Free Report) was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $8.20–$17.47 in the past one-month time frame, showed a sharp increase yesterday.
The company has seen one positive estimate revision in the past month, while its Zacks Consensus Estimate for the current quarter has also moved higher over the same time frame, suggesting that more solid trading could be ahead for Champions Oncology. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Champions Oncology currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Is CSBR going up? Or down? Predict to see what others think: Up or Down
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Champions Oncology (CSBR) Soars: Stock Adds 10.7% in Session
Champions Oncology, Inc. (CSBR - Free Report) was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $8.20–$17.47 in the past one-month time frame, showed a sharp increase yesterday.
The company has seen one positive estimate revision in the past month, while its Zacks Consensus Estimate for the current quarter has also moved higher over the same time frame, suggesting that more solid trading could be ahead for Champions Oncology. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Champions Oncology currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Champions Oncology, Inc. Price
Champions Oncology, Inc. Price | Champions Oncology, Inc. Quote
Another stock worth considering in the Medical – Drugs industry is BioSpecifics Technologies Corp. which also carries a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CSBR going up? Or down? Predict to see what others think: Up or Down
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>